Further to its announcement dated 28.12.2007, EUROMEDICA S.A. hereby announces that on 31.12.2007 the Deputy Minister of the Ministry of Development approved - by means of a relevant decision - the merger of the company by absorption of the "GENERAL CLINIC OF THESSALONIKI S.A.", the "MEDICAL INSTITUTE OF HIGH TECHNOLOGY OF CRETE S.A." and "EUROMEDICA WEST MACEDONIA S.A.", as well as the decision of the Extraordinary General Meeting of the company's shareholders regarding the increase in the share capital of ΕUROMEDICA S.A. by the amount of euros 8,888,420.75, through the issuance of 5,734,465 new ordinary (dematerialised) registered shares with a nominal value of euros 1.55 each. The former shareholders of the three absorbed companies shall be the beneficiaries of the new shares, in accordance with the share exchange ratio that has been approved by the General Meetings of the companies and has already been announced.
Furthermore, the shareholders of EUROMEDICA S.A. will also be the beneficiaries of the new shares, arising from the share capital increase due to the said absorption, who shall receive, for each old share with a nominal value of ?1.55 that they currently hold, an additional 0,04311986736 shares free of charge, i.e. they shall receive a total of 1,634,517 additional new shares with a nominal value of euros 1.55 and shall hold 39,540,872 shares instead of the 37,906,355 shares that they currently hold.
With regard to the above matter, the announcement of the company dated 28.12.2007 has been rectified and it is hereby clarified that the shareholders of EUROMEDICA S.A. who shall be entitled to the new shares shall be appointed by means of a subsequent decision of the company Board of Directors, following the receipt of the relevant approvals by the Athens Stock Exchange and the Capital Market Commission.